Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT00230633
Studies of White Blood Cells Derived From HHT Patients
Sponsor: Imperial College London
View on ClinicalTrials.gov
Summary
Hereditary Haemorrhagic Telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome) is an inherited vascular disease that leads to the development of dilated and fragile blood vessels. The study goal is to culture white blood cells that express the proteins mutated in HHT and examine in the laboratory to explain aspects of the HHT disease phenotype.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2002-04
Completion Date
2026-10
Last Updated
2023-09-28
Healthy Volunteers
Yes
Conditions
Locations (1)
Imperial College Hammersmith Campus
London, United Kingdom